ID   FLFMM-34
AC   CVCL_0I20
DR   cancercelllines; CVCL_0I20
DR   Wikidata; Q54834982
RX   PubMed=25639772;
CC   Population: Chinese; Han.
CC   Doubling time: 2-3 days (PubMed=25639772).
CC   Sequence variation: Mutation; HGNC; 1097; BRAF; Simple; p.Val600Glu (c.1799T>A); ClinVar=VCV000013961; Zygosity=Unspecified (PubMed=25639772).
CC   Sequence variation: Mutation; HGNC; 11998; TP53; Simple; p.Arg181His (c.542G>A); ClinVar=VCV000142320; Zygosity=Unspecified (PubMed=25639772).
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
DI   NCIt; C3224; Melanoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   47Y
CA   Cancer cell line
DT   Created: 10-04-15; Last updated: 05-10-23; Version: 10
//
RX   PubMed=25639772; DOI=10.1002/cbin.10417;
RA   Yi X.-L., Zhu G.-N., Li Y., Liu Y., Luan Q., Dai W., Wang L.,
RA   Liao W.-J., Gao T.-W., Li C.-Y.;
RT   "Establishment of a novel Chinese metastatic melanoma cell line
RT   showing the new cytogenetic and biological properties.";
RL   Cell Biol. Int. 39:508-514(2015).
//